4.4 Article

Female aging: when translational models don't translate

期刊

NATURE AGING
卷 -, 期 -, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s43587-023-00509-8

关键词

-

向作者/读者索取更多资源

Female patients have higher morbidity and more frequent adverse events from treatments compared to males in many age-related diseases. However, the commonly used preclinical models fail to replicate typical female aging trajectories and lack research on menopause, pregnancy, and other gender considerations. Therefore, it is necessary for aging biology researchers, journals, funding agencies, and animal providers to take action to address this gap.
For many pathologies associated with aging, female patients present with higher morbidity and more frequent adverse events from treatments compared to male patients. While preclinical models are the foundation of our mechanistic understanding of age-related diseases, the most common models fail to recapitulate archetypical female aging trajectories. For example, while over 70% of the top age-related diseases are influenced by the systemic effects of reproductive senescence, we found that preclinical studies that include menopausal phenotypes modeling those seen in humans make up <1% of published aging biology research. The long-term impacts of pregnancy, birthing and breastfeeding are also typically omitted from preclinical work. In this Perspective, we summarize limitations in the most commonly used aging models, and we provide recommendations for better incorporating menopause, pregnancy and other considerations of sex in vivo and in vitro. Lastly, we outline action items for aging biology researchers, journals, funding agencies and animal providers to address this gap.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据